Três triterpenos pentacíclicos inéditos foram isolados da resina de Protium kleinii. Suas estruturas, 3-oxo-11β,16β-diidróxi-urs-12-eno (1), 3-oxo-11β-hidróxi-urs-12-eno (2) e 3-oxo-11β-hidróxi-olean-12-eno (3), foram elucidadas por espectroscopia de RMN. A administração sistêmica destes compostos (10-100 mg kg -1 , i.p.) foi capaz de inibir tanto a primeira quanto a segunda fase da nocicepção induzida pela formalina em camundongos. Em adição, foram isolados os triterpenos conhecidos 3β,16β-dihidróxi-urs-12-eno (breina) (4) e uma mistura de α (5)-e β-amirina (6).
Introduction
Plants of the genus Protium (Burseraceae) are known for the production of a resin exudate used for skin diseases, healings of ulcers, scirrhous and as an analgesic. 1 Essential oils from the leaves and resin of various Protium spp. have been evaluated for their anti-inflammatory activity. 2, 3 Triterpenes, mainly of the oleane and ursane series, occur as binary mixtures in the resin. 4, 5 Protium kleinii Cuatrecas is endemic in southern Brazil, where it is known as "almecega", "almiscar", "pau-de-breu" and "guapoi", inter alia. 6 In an earlier paper 7 we reported the antinociceptive activity of the ether soluble portion and of 3β,16β-dihydroxy-urs-12-ene (brein) obtained from its resin.
In the present paper, we report the full phytochemical study of the resinous bark and the structural determination of three novel pentacyclic triterpenes, 3-oxo-11β,16β-dihydroxy-urs-12-ene (1), 3-oxo-11β-hydroxy-urs-12-ene (2) , and 3-oxo-11β-hydroxy-olean-12-ene (3), the last two isolated and analyzed as a mixture. The known triterpenes 3β,16β-dihydroxy-olean-12-ene (brein) (4) and a mixture of α (5)-and β-amyrin (6) were also found. Futhermore the present study was aimed at evaluating the possible antinociceptive action of this pentacyclic triterpenes in a chemical model of nociception in mice.
Results and Discussion
Conventional chromatographic separation of the ethyl ether soluble portion of the resinous bark led to the isolation of a mixture of α (5)-and β-amyrin (6) and of 3β,16β-dihydroxy-urs-12-en (brein) (4) as the main components. Compound 1 and an unseparable mixture of 2 and 3 were also obtained by extended purification and repeated crystallizations. (Table 1) .
Finally, decoupling experiments established the position 11 for the second hydroxymethine (δ C 81.7; δ H 4.59, dd, J 9.8 and 2.7 Hz). In fact, the irradiation at δ 4.59 (H-11) changes to singlets both signals at δ 5.44 (H-12) and at δ 1.98 (H-9). Conversely, by irradiating at δ 5.44 or at δ 1.98 the signal of H-11 becomes a doublet (J 2.7 Hz or J 9.8 Hz, respectively). Therefore, compound 1 is 3-oxo-11β,16β-dihydroxyurs-12-ene with the stereochemistry in 11 to be established.
Compounds 2 and 3 were obtained as a 2:3 mixture after repeated attempts of chromatographic purification and crystallization. The mixture showed a molecular peak in the mass spectrum at m/z 440 and analyzed for C 30 H 48 O 2 , but exhibited two sets of signals both in the 1 H and 13 C NMR spectra. In the proton spectrum were evident two doublets at δ 5.38 and 5.45 (J 2.8 Hz) (ratio 2:3) and two double doublet at δ 4.56 and 4.59 (J 9.4 and 2.8 Hz), which highly resemble the signals H-12 and H-11, respectively, of compound 1. The carbon spectrum disclosed fifty-six signals with a pair of signals at δ 124.8/121.2, at δ 146.1/ 152.8, at δ 218.0/217.8 and at δ 81.8/82.0. Therefore the mixture was considered to be constituted by two triterpenes of the ursane/oleane series with a carbonyl and an hydroxyl. Careful examination of the multiplicity of the signals in the DEPT experiment permitted the carbon assignments of 2 and of 3 as reported in Table 2 ; for instance, C-18 and C-19 are CH in the ursane 2, while they are CH and CH 2 , respectively, in the oleane 3. According to the method developed by Maia et al. 4 and Olea and Roque, 9 the assignments were corroborated by comparison with the data of ursane/oleane pairs in the literature, 10 by the relative intensity of the signals and by the Hetcor spectrum. In addition, in the Inept experiment the irradiation at δ 4.56- -14) . As for 1, decoupling experiments correlated the proton signals H-12, H-11 and H-9. In conclusion, the mixture is constituted of 3-oxo-11-hydroxy-urs-12-ene and 3-oxo-11-hydroxy-olan-12-ene. Literature survey for 11-hydroxy-ursane/oleanes led to two compounds, 3-oxo-11α-hydroxy-olean-12-ene (7) 11 and 3-oxo-11α-hydroxy-urs-12-ene (8), 12 whose 13 C NMR data are reported in Table 2 . Comparison between 2 and 7 revealed a large difference (+13.1 ppm) for the carbon 11 attributed to a different stereochemistry of the 11-OH (ipso effect). Differences can be also observed for C-9 (-6.6 ppm) and C-12 (-4.2 ppm), and for C-13 (+3.3 ppm). Therefore, it was concluded that compound 2 is the 11-epimer of 7, i.e. 3-oxo-11β-hydroxy-urs-12-ene. Similar differences were found between 3 and 8, therefore the compound 3 is 3-oxo-11β-hydroxy-olean-12-ene. Consequently, also previous compound 1 has a 11-β-hydroxy substituent. During the search in the literature a compound which claimed to be 3α,11α-dihydroxy-olean-12-ene, it was found. 13 Nevertheless, the signal for C-11 is reported at δ 81.8 so that its structure should be revised to 3α,11β-dihydroxy-olean-12-ene.
Recently was reported the isolation of 3β,16β,11α-trihydroxyurs-12-ene from Trattinnickia burserifolia. 14 The signals of 13 C NMR were δ 68.2 for C-11α and δ 66.7 for C-16β, being these values confirmed by NOESY experiments. Such important data confirm our previous conclusions.
The treatment of animals with (1) (10 -100 mg kg -1 , i.p.) or (mixture 2, 3) (10 -60 mg kg -1 , i.p.), given 30 min prior formalin injection, produced marked inhibition of both phases of formalin-induced nociception (Figure 1  and 2) . However, its antinociceptive effects were significantly more pronounced against the second phase of pain model. The calculated ID 50 's values for second phases were 26.9 (12.5 -58.1) and 53.5 (37.6 -76.1) mg kg -1 for compound (1) and (mixture 2,3), respectively. The maximal inhibitions observed for (1) were: 44 ± 1% and 76 ± 11% for the first and second phase, and (mixture 2, 3).were 54 ± 7% and 66 ± 12%, respectively. This is the 
Extraction and fractionation
The resinous bark (50 g) was powered and extracted with diethyl eter at room temperature for two weeks. After evaporation of the solvent, part (14.4 g) of the brown residue (33.4 g) was chromatographed on silica gel column with a gradient of EtOAc in hexane. Fractions 11-15 (eluted with hexane:EtOAc, 49/1, v/v) afforded after repeated crystallizations a 2:3 inseparable mixture (45 mg) of 3-oxo-11β-hydroxy-urs-12-ene (2) and 3-oxo-11β-hydroxyolean-12-ene (3). Fractions 21-32 (hexane: EtOAc, 24/1) (5 g) was constituted by an inseparable mixture of α (5)-and β-amyrin (6). Fractions 59-73 (hexane: EtOAc, 4/1) gave 3-oxo-11β, 16β-dihydroxy-urs-12-ene, (1), (35 mg). Fractions 81-83 (hexane:ethyl acetate, 1/1) was pure 3βb,16β-dihydroxy-urs-12-ene (brein), (4) (2.5 g).
The identification of the known compounds was performed by comparison of NMR data with those reported in the literature: mixture of α-and β-amyrin, 4 and 3β,16β,dihydroxy-urs-12-ene (brein). 14 
3-oxo-11β,16β-dihydroxy-urs-12-ene (1)
.
Pharmacological analysis
Animals. Male Swiss mice (25-35 g), housed at 22 ± 2°C temperature under a 12 h light/12 h dark cycle and with access to food and water ad libitum, were used. Experiments were performed during the light phase of the cycle. The animals were allowed to adapt to the laboratory for at least 2 h before testing and were used only once. Experiments reported in this study were carried out in accordance with current ethical guidelines for the investigation of experimental pain in conscious animals. 16 Formalin test. The procedure used was essentially similar to that described previously. Statistical analysis. The results are presented as means ± S.E.M., except the ID 50 values (it. the dose of (1) reducing the pain responses by 50% relative to the control value) which are reported as geometric means accompanied by their respective 95% confidence limits. Data were analyzed by analysis of variance (ANOVA) or t-test and complemented by Dunnett's or Newman Keul's post-hoc test. P values less than 0.05 (P < 0.05) were considered as indicative of significance. The ID 50 values were determined by linear regression from individual experiments using "GraphPad Software", and are reported as geometric means accompanied by their respective 95% confidence limits.
Drugs. The following substances were used: formalin (Merck, AG, Darmstadt, Germany), was dissolved in 0.9% m/v of NaCl solution just before injection while capsaicin and ether fraction which were dissolved in absolute ethanol
